Issue 7, 2015
From the journal:

MedChemComm

Correction: Synthesis and biological evaluation of N-(4-phenylthiazol-2-yl)cinnamamide derivatives as novel potential anti-tumor agents

Yong Luo,a   Yongxia Zhu,a   Kai Ran,a   Zhihao Liu,a   Ningyu Wang,a   Qiang Feng,ac   Jun Zeng,a   Lidan Zhang,b   Bing He,ac   Tinghong Ye,a   Shirui Zhu,d   Xiaolong Qiue  and  Luoting Yu*a  

* Corresponding authors

a Sichuan University, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China
E-mail: yuluot@scu.edu.cn
Fax: +86 28 8516 4060
Tel: +86 28 8516 4063

b Department of Pharmaceutical and Bioengineering, School of Chemical Engineering, Sichuan University, Chengdu, Sichuan 610065, China

c College of Chemistry and Life Science, Chengdu Normal University, Chengdu 611130, China

d Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan University of Traditional Chinese Medicine, Zhengzhou, China

e Wisdom Pharmaceutical Co. Ltd, Haimen, China

Abstract

Correction for 'Synthesis and biological evaluation of N-(4-phenylthiazol-2-yl)cinnamamide derivatives as novel potential anti-tumor agents' by Yong Luo et al., Med. Chem. Commun., 2015, 6, 1036.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C5MD90027A
Article type
Correction
Submitted
03 Jun 2015
Accepted
03 Jun 2015
First published
15 Jun 2015
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2015,6, 1404-1404

Permissions

Request permissions

Correction: Synthesis and biological evaluation of N-(4-phenylthiazol-2-yl)cinnamamide derivatives as novel potential anti-tumor agents

Y. Luo, Y. Zhu, K. Ran, Z. Liu, N. Wang, Q. Feng, J. Zeng, L. Zhang, B. He, T. Ye, S. Zhu, X. Qiu and L. Yu, Med. Chem. Commun., 2015, 6, 1404 DOI: 10.1039/C5MD90027A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements